Progranulin (human) BioAssay(TM) ELISA Kit (Proepithelin, PEPI, PC Cell-derived Growth Factor)

Catalog Number

045167

References

Product Reference: \n?Low plasma progranulin levels predict progranulin mutations in frontotemporal lobar degeneration: R. Ghidoni, et al.; Neurology 71, 1235 (2008)\n?Common variation in the miR-659 binding-site of GRN is a major risk factor for TDP43-positive frontotemporal dementia: R. Rademakers, et al.; Hum. Mol. Genet. 17, 3631 (2008)\n?Serum progranulin concentrations may be associated with macrophage Infiltration into omental adipose tissue: B.S. Youn, et al.; Diabetes 58, 627 (2009)\n?Plasma progranulin levels predict progranulin mutation status in frontotemporal dementia patients and asymptomatic family members: N. Finch, et al.; Brain 132, 583 (2009)\n?Progranulin plasma levels as potential biomarker for the identification of GRN deletion carriers. A case with atypical onset as clinical amnestic Mild Cognitive Impairment converted to Alzheimer's disease: M. Carecchio, et al.; J. Neurol. Sci. 287, 291 (2009)\n?Cerebrospinal fluid progranulin levels in patients with different multiple sclerosis subtypes: M. De Riz, et al.; Neurosci. Lett. 469, 234 (2010)\n?Low Serum Progranulin Predicts the Presence of Mutations: A Prospective Study: E.C. Schofield, et al.; J. Alzheimers Dis. 22, 981 (2010)\n?A Novel Progranulin Mutation Causing Frontotemporal Lobar Degeneration with Heterogeneous Phenotypic Expression: G. Rossi, et al.; J. Alzheimers Dis. 23, 7 (2010)\n?Pathogenic cysteine mutations affect progranulin function and production of mature granulins: J. Wang, et al.; J. Neurochem. 112, 1305 (2010)\n?Microglial upregulation of progranulin as a marker of motor neuron degeneration: T. Philips, et al.; J. Neuropathol. Exp. Neurol. 69, 1191 (2010)\n?A novel progranulin mutation causing frontotemporal lobar degeneration with heterogeneous phenotypic expression: G. Rossi, et al.; J. Alzheimers Dis. 23, 7 (2011)\n?rs5848 polymorphism and serum progranulin level: G.Y. Hsiung, et al.; J. Neurol. Sci. 300, 28 (2011)\n?Association of TMEM106B Gene Polymorphism With Age at Onset in Granulin Mutation Carriers and Plasma Granulin Protein Levels: C. Cruchaga, et al.; Arch. Neurol. 68, 581 2011\n?Progranulin expression in brain tissue and cerebrospinal fluid levels in multiple sclerosis: M. Vercellino, et al.; Mult. Scler. 17, 1194 (2011)\n?Soluble Beta-amyloid precursor protein is related to disease progression in amyotrophic lateral sclerosis: Steinacker, et al.; PLoS One. 6, e23600 (2011)\n?Loss of function mutations in the progranulin gene are related to pro-inflammatory cytokine dysregulation in frontotemporal lobar degeneration patients: P. Bossù, et al.; J. Neuroinflammation 8, 65 (2011)\n?Mucosal Progranulin expression is induced by H. pylori, but independent of Secretory Leukocyte Protease Inhibitor (SLPI) expression: T. Wex, et al.; BMC Gastroenterol. 11, 63 (2011)\n?Progranulin Genetic Screening in Frontotemporal Lobar Degeneration Patients From Central Italy: S. Bagnoli, et al.; Cell Mol. Neurobiol. 32, 13 (2011)\n?Optimal Plasma Progranulin Cutoff Value for Predicting Null Progranulin Mutations in Neurodegenerative Diseases: A Multicenter Italian Study: R. Ghidoni, et al.; Neurodegener. Dis. (Epub ahead of print) (2011)\n?Prevalence of frontotemporal lobar degeneration in an isolated population: the Vallecamonica study: N. Gilberti, et al.; Neurol. Sci. (Epub ahead of print) 2011\n?Granulin mutation drives brain damage and reorganization from preclinical to symptomatic FTLD: B. Borroni, et al.; Neurobiol. Aging. (Epub ahead of print) 2011\n?Mining the Gastric Cancer Secretome: Identification of GRN as a Potential Diagnostic Marker for Early Gastric Cancer: H. Loei, et al.; J. Proteome Res. (Epub ahead of print) 2012\n?

Alternative Names

Proepithelin, PEPI, PC Cell-derived Growth Factor